Here, we explored chromatin accessibility and transcription factor activities through ATAC‐seq profiling of 35 primary human AML samples followed by RNA‐seq, functional assays, and preclinical models to dissect the role of GPR56 in the identified network. The gene discussed is ADGRG1; the disease is acute myeloid leukemia.